Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Genetic screening.

Burke W, Tarini B, Press NA, Evans JP.

Epidemiol Rev. 2011;33:148-64. doi: 10.1093/epirev/mxr008. Epub 2011 Jun 27. Review.

2.

Genetic screening: marvel or menace?

Rowley PT.

Science. 1984 Jul 13;225(4658):138-44.

PMID:
6729472
3.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
4.

Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.

Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, Makholm LM, Shen G, Feenan L, McCarthy C, Farrell PM.

Pediatrics. 1998 Jul;102(1 Pt 1):44-52.

PMID:
9651412
5.

Options for Down syndrome screening: what will women choose?

Grant SS.

J Midwifery Womens Health. 2005 May-Jun;50(3):211-8. Review.

PMID:
15894999
7.

Prenatal genetic carrier testing using triple disease screening.

Eng CM, Schechter C, Robinowitz J, Fulop G, Burgert T, Levy B, Zinberg R, Desnick RJ.

JAMA. 1997 Oct 15;278(15):1268-72.

PMID:
9333269
8.

Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.

Audibert F, Gagnon A; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists.

J Obstet Gynaecol Can. 2011 Jul;33(7):754-67.

PMID:
21749753
9.

Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR.

J S C Med Assoc. 2006 Aug;102(7):241-9. Review.

PMID:
17319238
10.

Evaluating the benefits of antenatal screening: an alternative approach.

Shackley P, Cairns J.

Health Policy. 1996 May;36(2):103-15.

PMID:
10158764
11.

On the current dilemma of Down syndrome screening.

Rose NC.

Obstet Gynecol. 2006 Jan;107(1):2-3. No abstract available.

PMID:
16394031
12.

[Ethical aspects of prenatal screening for Down's syndrome].

Tóth A, Szabó J.

Orv Hetil. 2000 Oct 15;141(42):2293-8. Review. Hungarian.

PMID:
11076495
13.

Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.

Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB.

Pediatrics. 2004 Jun;113(6):1573-81.

PMID:
15173476
15.

Efficacy of the genetic sonogram in a stepwise sequential protocol for down syndrome screening.

Shamshirsaz AA, Ravangard SF, Turner G, Borgida A, Janicki MB, Campbell WA, Zelop C, Shamshirsaz AA, Spiel M, Prabulos AM, Feldman D, Rodis J, Ingardia CJ, Gurram P, Fuller K, Fang YM, Benn P, Egan JF.

J Ultrasound Med. 2013 Sep;32(9):1607-13. doi: 10.7863/ultra.32.9.1607.

16.
17.

Genetic testing in primary care.

Burke W.

Annu Rev Genomics Hum Genet. 2004;5:1-14. Review.

PMID:
15485341
18.

Introduction: new technologies for genetic and newborn screening.

Seashore MR, Walsh-Vockley C.

Yale J Biol Med. 1991 Jan-Feb;64(1):3-7.

19.

Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?

Bianchi DW, Oepkes D, Ghidini A.

Prenat Diagn. 2014 Jan;34(1):6-11. doi: 10.1002/pd.4229. Epub 2013 Sep 24. No abstract available.

PMID:
24002925
20.

Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.

Hinton CF, Grant AM, Grosse SD.

Ethn Health. 2011 Aug-Oct;16(4-5):377-88. doi: 10.1080/13557858.2010.541902.

PMID:
21797724
Items per page

Supplemental Content

Write to the Help Desk